全文获取类型
收费全文 | 758篇 |
免费 | 44篇 |
国内免费 | 2篇 |
专业分类
耳鼻咽喉 | 27篇 |
儿科学 | 2篇 |
妇产科学 | 9篇 |
基础医学 | 105篇 |
口腔科学 | 1篇 |
临床医学 | 38篇 |
内科学 | 158篇 |
皮肤病学 | 4篇 |
神经病学 | 29篇 |
特种医学 | 58篇 |
外科学 | 184篇 |
综合类 | 2篇 |
预防医学 | 15篇 |
眼科学 | 4篇 |
药学 | 33篇 |
肿瘤学 | 135篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 22篇 |
2020年 | 8篇 |
2019年 | 11篇 |
2018年 | 29篇 |
2017年 | 17篇 |
2016年 | 31篇 |
2015年 | 29篇 |
2014年 | 52篇 |
2013年 | 56篇 |
2012年 | 65篇 |
2011年 | 82篇 |
2010年 | 53篇 |
2009年 | 36篇 |
2008年 | 47篇 |
2007年 | 53篇 |
2006年 | 37篇 |
2005年 | 33篇 |
2004年 | 30篇 |
2003年 | 26篇 |
2002年 | 17篇 |
2001年 | 18篇 |
2000年 | 16篇 |
1999年 | 7篇 |
1998年 | 1篇 |
1997年 | 5篇 |
1996年 | 1篇 |
1994年 | 1篇 |
1993年 | 3篇 |
1986年 | 2篇 |
1984年 | 1篇 |
1982年 | 2篇 |
1961年 | 3篇 |
排序方式: 共有804条查询结果,搜索用时 312 毫秒
1.
W. Feleszko J. Jaworska R-D. Rha S. Steinhausen A. Avagyan A. Jaudszus B. Ahrens D. A. Groneberg U. Wahn E. Hamelmann 《Clinical and experimental allergy》2007,37(4):498-505
BACKGROUND: Microbial intestinal colonization in early in life is regarded to play a major role for the maturation of the immune system. Application of non-pathogenic probiotic bacteria during early infancy might protect from allergic disorders but underlying mechanisms have not been analysed so far. OBJECTIVE: The aim of the current study was to investigate the immune effects of oral application of probiotic bacteria on allergen-induced sensitization and development of airway inflammation and airway hyper-reactivity, cardinal features of bronchial asthma. METHODS: Newborn Balb/c mice received orally 10(9) CFU every second day either Lactobacillus rhamnosus GG or Bifidobacterium lactis (Bb-12) starting from birth for consecutive 8 weeks, during systemic sensitization (six intraperitoneal injections, days 29-40) and airway challenge (days 54-56) with ovalbumin. RESULTS: The administration of either Bb-12 or LGG suppressed all aspects of the asthmatic phenotype: airway reactivity, antigen-specific immunoglobulin E production and pulmonary eosinophilia (mean: 137 vs. 17 and 13 cellsx10(3)/mL, respectively). Antigen-specific recall proliferation by spleen cells and T-helper type 2 cytokine production (IL-4, IL-5 and IL-10) by mesenteric lymph node cells also showed significant reduction, while TGF production remained unchanged. Oral LGG administration particularly suppressed allergen-induced proliferative responses and was associated with an increase in numbers of TGF-beta-secreting CD4+/CD3+ T cells in mesenteric lymph nodes (6.5, 16.7%) as well as nearly 2-fold up-regulation of Foxp3-expressing cells in peribronchial lymph nodes. CONCLUSIONS: Neonatal application of probiotic bacteria inhibits subsequent allergic sensitization and airway disease in a murine model of asthma by induction of T regulatory cells associated with increased TGF-beta production. 相似文献
2.
Min-Seok Rha Hye Won Jeong Jae-Hoon Ko Seong Jin Choi In-Ho Seo Jeong Seok Lee Moa Sa A Reum Kim Eun-Jeong Joo Jin Young Ahn Jung Ho Kim Kyoung-Ho Song Eu Suk Kim Dong Hyun Oh Mi Young Ahn Hee Kyoung Choi Ji Hoon Jeon Jae-Phil Choi Eui-Cheol Shin 《Immunity》2021,54(1):44-52.e3
- Download : Download high-res image (218KB)
- Download : Download full-size image
3.
Jong Jin Oh Sangchul Lee Ja Hyeon Ku Tae Gyun Kwon Tae-Hwan Kim Seung Hyun Jeon Sang Hyup Lee Jong Kil Nam Wan Seok Kim Byong Chang Jeong Ji Youl Lee Sung Hoo Hong Koon Ho Rha Woong Kyu Han Won Sik Ham Young Goo Lee Yong Seong Lee Sung Yul Park Young Eun Yoon Sung Gu Kang Seok Ho Kang Korean Robot Assisted Radical Cystectomy Study Group 《BJU international》2021,127(2):182-189
4.
Zafer Tandogdu Justin Collins Greg Shaw Jennifer Rohn Bela Koves Ashwin Sachdeva Ahmed Ghazi Alexander Haese Alex Mottrie Anup Kumar Ananthakrishnan Sivaraman Ashutosh Tewari Benjamin Challacombe Bernardo Rocco Camilo Giedelman Christian Wagner Craig G. Rogers Declan G. Murphy Dmitry Pushkar Gabriel Ogaya-Pinies James Porter Kulthe Ramesh Seetharam Markus Graefen Marcelo A. Orvieto Marcio Covas Moschovas Oscar Schatloff Peter Wiklund Rafael Coelho Rair Valero Theo M. de Reijke Thomas Ahlering Travis Rogers Henk G. van der Poel Vipul Patel Walter Artibani Florian Wagenlehner Kris Maes Koon H. Rha Senthil Nathan Truls Erik Bjerklund Johansen Peter Hawkey John Kelly 《BJU international》2021,127(6):729-741
5.
Jo-Lynn S. Tan Niranjan Sathianathen Marcus Cumberbatch Prokar Dasgupta Alexandre Mottrie Ronney Abaza Koon Ho Rha Thyavihally B. Yuvaraja Dipen J. Parekh Umberto Capitanio Rajesh Ahlawat Sudhir Rawal Nicolò M. Buffi Ananthakrishnan Sivaraman Kris K. Maes Gagan Gautam Francesco Porpiglia Levent Turkeri Mahendra Bhandari Benjamin Challacombe James Roscoe Porter Craig R. Rogers Daniel A. Moon 《BJU international》2021,128(Z3):30-35
6.
7.
Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression 总被引:10,自引:0,他引:10
Sun Young Rha Joo Hang Kim Jae Kyung Roh Kyong Sik Lee Jin Sik Min Byung Soo Kim Hyun Cheol Chung 《Breast cancer research and treatment》1997,43(2):175-181
The degradation of the basement membrane by matrix-metalloproteinase(MMP) and serine protease is a critical pointin tumor invasion and metastasis. We measured theactivity of MMP-9 from 28 normal, 12 benignand 126 breast cancer tissues using gelatin zymographywith an image analysis system. ProMMP-9 was expressedin 17.5% of the cancer patients compared to2.5% in 40 non-cancerous tissues (p=0.014).The mature form of MMP-9 (82 kD) wasexpressed only in T2–T4 stages. During the earlyphase of breast cancer (DCIS and T1 stage)progression, only production of proMMP-9 increased. However, asthe cancer grew or invaded skin (T2–T4), orwith lymphovascular permeation, both production and activation ofMMP-9 increased. In conclusion, proMMP-9 production was themain cause of increased MMP-9 activity during theearly phase, while both production and activation increasedin the late phase of breast cancer. 相似文献
8.
9.
10.
Sang Rok Lee Myung Ho Jeong Young Keun Ahn Shung Chull Chae Seung Ho Hur Young Jo Kim In Whan Seong Jei Keon Chae Taek Jong Hong Jae Young Rhew Myeong Chan Cho Jang Ho Bae Seung Woon Rha Chong Jin Kim Yang Soo Jang Seung Jung Park 《Circulation journal》2008,72(3):392-398
BACKGROUND: Percutaneous coronary intervention (PCI) with drug-eluting stents (DES) may be useful in patients with acute myocardial infarction (AMI), but safety issues still need to be solved. This study was undertaken to investigate the incidence of major adverse cardiac events (MACE) and stent thrombosis in DES-implanted AMI patients in real-life clinical practice. METHODS AND RESULTS: On-line registry of AMI cases at the web site www.kamir.or.kr has been performed in 41 primary PCI centers in Korea and between November 2005 and September 2006, 1,541 surviving patients who had been implanted with either Cypher or Taxus stents were enrolled for analysis during a 6-month clinical follow-up. There were 2 groups: group I [834 patients, 61.9+/-11.9 years: sirolimus-eluting stent (Cypher)], group II [707 patients, 62.9+/-12.0 years: paclitaxel-eluting stent (Taxus)]. At both 1 and 6 months the incidence of MACE was not significantly different between the 2 groups. There were 17 cases of stent thrombosis, but the incidence of stent thrombosis was not significantly different between the 2 groups (group I:II=9 (1.1%):8 (1.1%), p=1.000). The stent type, length, number, lesion complexity and diabetes were not significant for the incidence of MACE or stent thrombosis after adjustment. CONCLUSION: MACE and stent thrombosis rates did not differ between 2 types of DES identified in Korea Acute Myocardial Infarction Registry (KAMIR). DES can be used in patients with AMI with a relatively low 6-month MACE rate. 相似文献